All lists
Edited biology
A commercial gene-editing name, an AI-biology platform, and a consumer health brand.
Healthcare stories get flattened into “biotech.” This list refuses that. One has an approved therapy, one is a platform in search of more data, one sells subscriptions to consumers. Read them as three files.
| # | Company | Price | Change | Volume | Session | Pin |
|---|---|---|---|---|---|---|
| 1 | CRISPR TherapeuticsCRSP · Nasdaq | 58.74 | +12.7% | 3.4M | ||
| 2 | Recursion PharmaceuticalsRXRX · Nasdaq | 7.05 | +8.8% | 8.6M | ||
| 3 | Hims & Hers HealthHIMS · NYSE | 22.40 | +12.8% | 14.2M |
- 1CRISPR TherapeuticsCRSP · Nasdaq58.74+12.7%3.4M
- 2Recursion PharmaceuticalsRXRX · Nasdaq7.05+8.8%8.6M
- 3Hims & Hers HealthHIMS · NYSE22.40+12.8%14.2M
